Trustmark (TRMK)
(Delayed Data from NSDQ)
$32.25 USD
+0.72 (2.28%)
Updated Jul 15, 2024 04:00 PM ET
After-Market: $32.28 +0.03 (0.09%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$32.25 USD
+0.72 (2.28%)
Updated Jul 15, 2024 04:00 PM ET
After-Market: $32.28 +0.03 (0.09%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth A Momentum D VGM
Zacks News
Amerant Bancorp Inc. (AMTB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Amerant Bancorp Inc. (AMTB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Trustmark (TRMK) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Trustmark (TRMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trustmark (TRMK) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Trustmark (TRMK) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Trustmark (TRMK) Lags Q3 Earnings Estimates
by Zacks Equity Research
Trustmark (TRMK) delivered earnings and revenue surprises of -7.25% and 1.51%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Raymond James (RJF) in Q4 Earnings?
by Zacks Equity Research
Higher interest rates, decent loan demand and past buyouts are expected to have supported Raymond James' (RJF) fiscal Q4 earnings amid weakness in IB and trading businesses.
Invesco (IVZ) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Manageable expense level and decent AUM balance are likely to have aided Invesco's (IVZ) Q3 earnings amid subdued market performance.
Southern First (SFST) Beats Q3 Earnings Estimates
by Zacks Equity Research
Southern First (SFST) delivered earnings and revenue surprises of 54.55% and 4.71%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
First Bancorp (FBNC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
First Bancorp (FBNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trustmark (TRMK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Trustmark (TRMK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Trustmark (TRMK) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Down -10.06% in 4 Weeks, Here's Why You Should You Buy the Dip in Trustmark (TRMK)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Trustmark (TRMK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
AUM Growth to Aid BlackRock's (BLK) Top Line Amid Cost Woes
by Zacks Equity Research
A continued rise in expenses may hurt BlackRock's (BLK) bottom-line growth. However, efforts to restructure the active equity business will likely aid the top line.
5 Reasons to Add Popular (BPOP) Stock to Your Portfolio Now
by Zacks Equity Research
Popular (BPOP) stock looks like an attractive investment option now, supported by strong fundamentals and decent growth prospects.
Earnings Estimates Moving Higher for Trustmark (TRMK): Time to Buy?
by Zacks Equity Research
Trustmark (TRMK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Trustmark (TRMK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Trustmark (TRMK) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Trustmark (TRMK) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Trustmark (TRMK) delivered earnings and revenue surprises of 23.33% and 6.54%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Trustmark (TRMK) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Trustmark (TRMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Trustmark (TRMK) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Trustmark (TRMK) stock based on the movements in the options market lately.
5 Reasons to Add National Bank (NBHC) to Your Portfolio Now
by Zacks Equity Research
Supported by strong fundamentals and good growth prospects, the National Bank (NBHC) stock seems to be a viable investment option now.
4 Reasons to Add First BanCorp. (FBP) to Your Portfolio Now
by Zacks Equity Research
Supported by strong fundamentals and good growth prospects, First BanCorp. (FBP) stock seems to be a viable investment option now.
Synchrony (SYF) Ties Up to Better Serve the Hearing Care Space
by Zacks Equity Research
Synchrony Financial (SYF) aims to extend financing options to customers of Miracle-Ear who are in need of quality hearing care.
5 Reasons Why Trustmark Corporation (TRMK) Stock Is a Must Buy
by Zacks Equity Research
A solid loan and deposit balance, higher rates and a focus on improving fee income are likely to continue to support Trustmark Corporation's (TRMK) financials going forward.
All You Need to Know About Trustmark (TRMK) Rating Upgrade to Strong Buy
by Zacks Equity Research
Trustmark (TRMK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Value Stocks to Buy for June 6th
by Zacks Equity Research
E, MTH and TRMK made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 6, 2023.
Compared to Estimates, Trustmark (TRMK) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Trustmark (TRMK) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.